Revenue up 5%: is this small-cap company a stock to buy?

Consistent progress from the business behind this stock makes it look like one to consider now as a buy for the long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Abstract bull climbing indicators on stock chart

Image source: Getty Images

I reckon there’s a bright future for FTSE SmallCap stock Porvair (LSE: PRV), but is it one to buy now? Well, it’s certainly on my focus list.

I like the firm’s long-term record of steady operational progress. Over the past 10 years, revenue’s notched up a compound annual growth rate (CAGR) of 6% and adjusted earnings per share of 10%.

They’re not the kind of exciting numbers that raise pulses to dangerous levels. However, the financial and trading record shows consistent improvement. In short, the stock looks a decent candidate to consider for a long-term investment.

Porvair operates in the specialist filtration, laboratory and environmental technology sectors. The directors aim to focus on markets with long-term growth potential. On top of that, the company seeks to serve areas where “product use is mandated and replacement demand is regular”.

Well-financed organic and acquisitive growth

I reckon that approach might be one of the key drivers behind the firm’s consistent growth and trading over the past few years.

Porvair’s operating segments are Aerospace & Industrial, Laboratory and Metal Melt Quality, all of which the directors insist have “clear” long-term growth drivers. Meanwhile, the progress of the overall business has been both organic and via acquisitions. So I’d expect more of the same ahead.

Today’s (1 July) interim results statement shows year-on-year revenue grew by 5% in the six months to 31 May. Although at constant currency rates, the rise was 8%.

However, currency adjusted underlying sales revenue actually fell by 3%. The overall rise occured because of the effects of prior acquisitions.

That weakness in like-for-like performance was caused by softening in the industrial and laboratory consumables markets. There was a trend among customers of reducing inventory levels “and more normal lead times through 2023 and 2024”.

De-stocking combined with adverse currency exchange rates to cause the firm’s profit margins to drop a bit too.

The situation demonstrates that Porvair’s operations are sensitive to general economic and cyclical influences. So the growth trajectory here’s unlikely to ever be straight up. As with most businesses, we could see volatility for operations and the stock over the coming years.

It’s one of the risks here and has the potential to cause a losing investment for shareholders. The directors said today that Inconsistency in trading patterns across the Group is not unusual”.

Anticipating a strengthening second half

Nevertheless, the company expects underlying market growth to return during the second half of the trading year. On top of that, the long-term growth drivers of Porvair’s operating sectors are robust. And chief executive Ben Stocks said the business looks set to move into 2025 “in good shape”.

City analysts anticipate mid-single-digit percentage advances for earnings and the dividend next year. Set against those estimates and with the share price near 668p, the forward-looking earnings multiple is just below 17. And the anticipated dividend yield’s a little under 1%.

That’s not the cheapest valuation in the world. But the balance sheet looks strong and multi-year trading performance has been consistent overall. I’d dive in with deeper research, then watch this one with a view to considering the stock on market dips and down-days.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended Porvair Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Road 2025 to 2032 new year direction concept
Investing Articles

Down 10% in a month with a near-7% yield — are Aviva shares the perfect ISA buy?

Harvey Jones says stock market volatility could give investors the opportunity to snap up Aviva shares at a reduced price…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

£5,000 invested in Diageo shares 1 month ago is now worth…

Diageo shares have dipped below £14 recently, taking the one-year fall to 31%. So why has one leading broker turned…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

Elon Musk could give Scottish Mortgage shares a huge boost!

Dr James Fox explains why Scottish Mortgage shares could benefit massively as Elon Musk looks to take SpaceX public later…

Read more »

Investing Articles

As Rolls-Royce and Babcock rocket, has the BAE Systems share price finally run out of juice?

Harvey Jones is astonised at recent sluggish performance of the BAE Systems share price and wonders if there is better…

Read more »

Investing Articles

10 dirt-cheap shares to consider after the correction

Investors keen to contribute to their ISA allowance before Sunday's deadline have a brilliant opportunity to buy cheap shares due…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Down 31% and with a P/E of 8.8, is this FTSE 100 share too cheap to ignore?

Berkeley's share price has collapsed to its cheapest in roughly 10 years. Is the FTSE share now too cheap to…

Read more »

UK supporters with flag
Investing Articles

Why I think this super-cheap growth stock will lead the charge when the FTSE 100 recovers

Harvey Jones is seriously excited by this FTSE 100 growth stock but he also cautions that it can be very…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Rolls-Royce’s share price is rallying again! But for how long?

Rolls-Royce's share price is the FTSE 100's best performer at the start of the new month. The question is, can…

Read more »